First enzymes will target NGS-based diagnostics, RNA-directed viral diagnostics and RNA manufacturing REDWOOD CITY, Calif. and JUPITER, Fla.– Codexis, Inc., (Nasdaq: CDXS), a leading protein engineering company and developer of high-performance enzymes, and Alphazyme LLC, an emerging leader in the development and manufacture of nucleic acid metabolizing enzymes, announce a Co-Marketing & Enzyme Supply Collaboration Agreement for […]

Until a COVID-19 Vaccine is Available, Widespread Environmental Testing for SARS-CoV-2, Coupled with Effective Disinfection Regimen, Shortens Path to Preserving Public Confidence and Enabling Facilities to Remain Open Amidst Periodic Flare-Ups New Brunswick, Canada – LuminUltra, the Canadian biotechnology leader and developer of the GeneCount qPCR system, and Florida-based Source Molecular, a leader in pathogen testing, […]

SOUTH SAN FRANCISCO, Calif.– Proteona today announced that Twist Bioscience Corporation (Nasdaq: TWST) will join the international alliance led by Proteona to develop neutralizing antibody therapy against COVID-19 for vulnerable immunocompromised patients. Utilizing the highly parallel silicon-based DNA synthesis platform, Twist has the ability to manufacture millions of oligos of different lengths with industry leading accuracy. This […]

Cambridge, UK – Genestack Ltd. today announced that its flagship multi-omics data catalogue, curation and integrative search product, Omics Data Manager (ODM), has been licensed and implemented by AstraZeneca. Genestack’s ODM is an enabling technology providing a central hub for organising and querying multi-omics data from multiple sites, including transcriptomics and proteomics. Curation tools, such as ODM, will enable AstraZeneca […]

With extended applications, Tapestri Designer, the only AI-powered cloud-based tool for single-cell panel designs, will improve drug development and CRISPR quality control studies SOUTH SAN FRANCISCO, California. Mission Bio, Inc., the pioneer in high-throughput single-cell DNA and multi-omics analysis, today announced extended capabilities for Tapestri Designer, the first-ever automated, cloud-based tool for designing targeted single-cell […]

ANN ARBOR, Mich. —Swift Biosciences, Inc., a leader in commercialization of DNA and RNA library preparation kits for Next-Generation Sequencing (NGS), has announced the release of its Swift Normalase™ Amplicon Panel (SNAP) SARS-CoV-2 kit. Targeting the full viral genome in a single tube reaction with a rapid 2-hour workflow, Swift’s assay enables research and surveillance activities […]

A new study has been initiated to evaluate whole-genome and RNA-sequencing as a first line diagnostic approach for patients in Sweden with acute leukemia. The study is conducted jointly by the national R&D platform Genomic Medicine Sweden and the biotech company Illumina – and is coordinated from Karolinska Institutet. Richard Rosenquist Brandell, photo: Creo Media […]

• Multiple studies presented in virtual 2020 ASCO Annual Meeting highlight the impact of QIAGEN’s Sample to Insight portfolio on improving knowledge about cancer and improving patient outcomes • QCI Interpret One combines QIAGEN Clinical Insights solutions with trusted N-of-One services to deliver gold-standard interpretation of somatic variants in cancer patients • QIAseq Pan-cancer Multimodal […]

Oxford Nanopore Technologies has raised £48.4M ($59.2M) in new capital.  The funding comes from new investors and existing shareholders in EMEA, US and Asia, and adds to the £29M of new capital raised in Q4 2019. Further information on Oxford Nanopore’s fundraising will be made available after full closing. Oxford Nanopore’s sequencing devices are used […]

Genomics insights generated through sequencing an individual’s DNA play a critical role in personalised healthcare and clinical diagnostics of the future Roche is committed to developing a nanopore sequencer with the aim of providing the healthcare community and ultimately patients with faster and more accurate medical information to predict risk and detect disease This investment […]